[HTML][HTML] Increased co-expression of CTLA4/LAG3 predicted adverse clinical outcomes in patients with T-cell malignancies
P Wang, Q Cai, X Peng, Z Dai, J Liu, W Li, R Lin, Y Liu… - Cell Investigation, 2025 - Elsevier
The application of immune checkpoint blockers (ICBs) in immunotherapy has markedly
improved the prognosis for patients with solid tumors and B-cell lymphomas, and it holds …
improved the prognosis for patients with solid tumors and B-cell lymphomas, and it holds …
恶性黑色素瘤靶向治疗及其耐药机制研究进展
刘一帆， 罗星， 宋天慈， 杨志惠 - 昆明医科大学学报, 2025 - kyxuebao.kmmu.edu.cn
恶性黑色素瘤是一种侵袭性极强的肿瘤, 在早期可行外科手术切除治疗. 晚期黑色素瘤细胞的
侵袭能力和增殖能力不断增强, 传统治疗方法如放疗, 化疗和免疫治疗等效果有限, 患者预后差 …
侵袭能力和增殖能力不断增强, 传统治疗方法如放疗, 化疗和免疫治疗等效果有限, 患者预后差 …
Research Progress on Targeted Therapy and Resistance Mechanisms of Malignant Melanoma
LIU Yifan, LUO Xing, S Tianci, Y Zhihui - 昆明医科大学学报, 2025 - kyxuebao.kmmu.edu.cn
Malignant melanoma is an extremely aggressive tumor that can be surgically treated in its
early stage. In advanced stages, the invasive and proliferative capabilities of melanoma …
early stage. In advanced stages, the invasive and proliferative capabilities of melanoma …
Microbiota Boost Immunotherapy? A Meta-Analysis Dives into Fecal Microbiota Transplantation and Immune Checkpoint Inhibitors
Background: Immune checkpoint inhibitors (ICIs) are a cornerstone of modern cancer
treatment, but their effectiveness is limited. Fecal microbiota transplantation (FMT), which …
treatment, but their effectiveness is limited. Fecal microbiota transplantation (FMT), which …
[PDF][PDF] Cell Investigation
P Wang, Q Cai, X Peng, Z Dai, J Liu, W Li, R Lin, Y Liu… - researchgate.net
The application of immune checkpoint blockers (ICBs) in immunotherapy has markedly
improved the prognosis for patients with solid tumors and B-cell lymphomas, and it holds …
improved the prognosis for patients with solid tumors and B-cell lymphomas, and it holds …